P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
about
Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferaseINSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylasesADA3-containing complexes associate with estrogen receptor alphaLigand-independent activation of oestrogen receptor alpha by caveolin-1Cdc25B functions as a novel coactivator for the steroid receptorsMetastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulatorCyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationThe pathology of familial breast cancer: Immunohistochemistry and molecular analysisAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyThe proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction.Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroDCyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein IICyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitmentCyclin D as a therapeutic target in cancerCyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanismA central domain of cyclin D1 mediates nuclear receptor corepressor activityCyclin D1: polymorphism, aberrant splicing and cancer riskHsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinaseAdenovirus E1A requires the yeast SAGA histone acetyltransferase complex and associates with SAGA components Gcn5 and Tra1.Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy.Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.PCAF interacts with tax and stimulates tax transactivation in a histone acetyltransferase-independent mannerRegulation of the functional interaction between cyclin D1 and the estrogen receptor.Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 functionCyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNANew roles of cyclin D1.High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics.Endocrine-responsive breast cancer and strategies for combating resistance.Nonhistone protein acetylation as cancer therapy targets.Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.Consequence of the tumor-associated conversion to cyclin D1bCyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.The elements of human cyclin D1 promoter and regulation involved.Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors
P2860
Q24292319-D12A04D3-4050-41E9-84A6-C03A1B189924Q24303548-A5E6E282-B232-426A-9BDF-F3B70FB869DFQ24311334-AB3D0695-5CB7-4F33-A6A0-FEE5FB702E33Q24530010-83AC158F-0382-436B-B19E-EC3D78738134Q24533468-01464912-3714-41A5-A024-DBE7BC07D37EQ24548253-6C5002CC-1A26-43D1-8BB1-744EF51DA588Q24564251-A530CCA2-4952-4CA4-BC31-78163B3ACDADQ24684054-9E03BE93-7E2F-49AD-896B-D79AC57D4730Q24800411-016A7F17-4DD2-41B9-95DD-2D29B41CAC5EQ24803990-1B1B92D4-364B-4F68-A319-429C37E235C5Q24815982-8A63871C-F5BF-448E-92B3-7B1D50741455Q27824813-0138639C-3079-4F22-BAAF-608208CDA360Q28215336-C20449B6-416C-4F24-8D5B-72E02BFB2D81Q28217630-A59EB570-F035-4260-8F24-49E6471955A5Q28235209-52DE5ED3-EAD5-4D15-803E-9AB2C2A48822Q28242623-904292B1-78AB-40DB-9B0F-4FB8EC8E54B9Q28256059-254BB16F-337E-49C7-82C7-71DAA92DA5DAQ28294586-03987960-03FE-4F4A-8E4E-752A655306BAQ28303053-43F27ADA-0F6B-4FFD-B9F1-C0AAE3A93011Q28585533-2A1AB468-CAC9-4465-B214-E3F5343E996FQ30308769-3967C37E-03C2-4FDA-96B2-387881F5AD0DQ33337386-2C04CE52-4B22-49D1-88B7-A59493E8E335Q33428469-56D3E902-9547-4043-8DB1-19AD2FA437EAQ33631775-1EA2590D-10EB-44CE-B64B-81C1F3D18922Q33847709-36A52A84-756E-4E0B-9E71-AAE1C21D6879Q33940612-2097EBC1-43EF-467E-B705-F02BE65AEF6CQ33960604-0F4DF288-44BF-43F2-B1D2-4D7E0E956775Q33966444-FB78758C-E4AD-451C-9B59-51752DE097C1Q33967106-EA0B2376-0264-4CD3-8FAB-ACC81D977A51Q34124151-2B4584A4-5522-4392-A0A9-2872A1BFE0B3Q34167898-97084961-0039-4835-B6ED-F323C6522515Q34352513-079A129A-E1C5-4523-8240-BE693D3F41E4Q34473061-7B342880-45B4-4B84-8D48-50D9BE5C5694Q35084786-77D903CC-FB0B-4017-9A97-B41AA54FA6AEQ35739676-D9DEE73E-C34F-4879-9857-0DE597F9F50BQ35746546-E44C54F7-BBA7-4CF6-8FC5-25BF1D6F188AQ35822584-C86D223A-CDEB-401A-BF71-CC4140A368FCQ35829500-C19356EF-1B95-4ECA-81DE-C5F6B41F898DQ36002446-A3AD5295-5B9B-49AD-80D6-AEFEC34794EAQ36188773-F8185A49-26A7-4A9F-AA99-46FA02AA98C7
P2860
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@ast
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@en
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@nl
type
label
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@ast
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@en
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@nl
prefLabel
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@ast
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@en
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@nl
P2093
P2860
P356
P1476
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
@en
P2093
T Suthiphongchai
P2860
P304
P356
10.1073/PNAS.96.10.5382
P407
P577
1999-05-11T00:00:00Z